Prolonged VV‐ECMO as a Bridge to Recovery From Persistent Hepatopulmonary Syndrome After Liver Transplantation: A Case Report Authors: Paweł Topolewski, Joanna Banatkiewicz, Wojciech Figiel, Anna Drobińska, Monika Budnik, Piotr Remiszewski, Katarzyna Błońska, Waldemar Patkowski, Mariusz Kuśmierczyk, Michał Grąt Published: 2026 ABSTRACT ABSTRACTIn persistent HPS‐related hypoxemia after LT, prolonged VV‐ECMO can serve as a bridge to recovery when conventional oxygenation strategies fail. Serial contrast‐enhanced echocardiography and multidisciplinary management may support weaning decisions and the management of ECMO‐related complications. Introduction Hepatopulmonary syndrome (HPS) is a pulmonary vascular complication of liver cirrhosis and a recognized indication for liver transplantation (LT). In rare cases, profound hypoxemia after LT necessitates extracorporeal membrane oxygenation (ECMO) as a bridge to recovery [1]. HPS is characterized by intrapulmonary vascular dilatation and right‐to‐left shunting and occurs in approximately 10%–30% of patients awaiting LT [2]. Most published reports describe ECMO runs shorter than 30 days, and the optimal duration of ECMO support has not been established. Successful prolonged ECMO runs have nevertheless been reported, including a 67‐day course in a 17‐year‐old patient and a 92‐day course in a pediatric patient [3, 4]. These cases suggest that prolonged support may provide a bridge to recovery while HPS gradually resolves. However, experience with ECMO beyond 30 days in post‐transplant HPS remains very limited. Case Presentation Patient Information and Clinical History We report the case of an 18‐year‐old man with end‐stage liver disease secondary to post‐traumatic cirrhosis. The patient underwent right hemihepatectomy for traumatic liver injury at 4 years of age and subsequently developed cirrhosis and portal hypertension. Cirrhosis was diagnosed at 11 years of age, and portal hypertension required endoscopic esophageal variceal ligation. One year before LT, he developed progressive dyspnea and perioral cyanosis, prompting further evaluation. Diagnostic Assessment The diagnosis of HPS was established based on chronic liver disease, impaired arterial oxygenation, and evidence of intrapulmonary vascular dilatation demonstrated by contrast‐enhanced echocardiography and pulmonary perfusion scintigraphy. Additional autoimmune, viral, and genetic testing, including assessment for Wilson disease and alpha‐1 antitrypsin deficiency, did not identify an alternative etiology of the underlying liver disease. Arterial blood gas analysis obtained in the upright position while breathing room air showed a pH of 7.469, PaCO2 of 27 mmHg, PaO2 of 63 mmHg, and arterial oxygen saturation of 91.1%, with a calculated alveolar–arterial oxygen gradient of approximately 53 mmHg. Based on the room‐air PaO2 of 63 mmHg, HPS was classified as moderate. Contrast‐enhanced transthoracic echocardiography showed microbubbles appearing in the left atrium beginning three cardiac cycles after right‐sided opacification, consistent with an intrapulmonary right‐to‐left shunt. Therapeutic Intervention The patient underwent deceased‐donor piggyback LT with hepaticojejunostomy. VV‐ECMO was planned and initiated at the beginning of the LT procedure. Intraoperative contrast‐enhanced transesophageal echocardiography performed during the initial VV‐ECMO cannulation showed microbubbles appearing in the left atrium four cardiac cycles after right‐sided opacification, consistent with persistent intrapulmonary right‐to‐left shunting. The postoperative course was complicated by hepatic vascular flow disturbances requiring surgical revision of the portal vein, hepatic artery arteriography with angioplasty and stent placement, and splenic artery embolization. The first VV‐ECMO run lasted 16 days, and the patient was decannulated on postoperative day 16 after improvement in oxygenation. However, refractory hypoxemia subsequently recurred despite mechanical ventilation with an FiO2 of 1.0 and inhaled nitric oxide. Immediately before VV‐ECMO re‐initiation, arterial blood gas analysis showed a PaO2 of 39.6 mmHg, corresponding to a PaO2/FiO2 ratio of 39.6 mmHg. VV‐ECMO was therefore re‐initiated on postoperative Day 20. During the second VV‐ECMO run, bilateral pneumothoraces required chest tube drainage. Respiratory function subsequently improved, allowing discontinuation of mechanical ventilation. Serial contrast‐enhanced echocardiography, performed approximately every 5 days, initially showed persistent right‐to‐left shunting. After 32 days of the second VV‐ECMO run, contrast‐enhanced echocardiography demonstrated markedly reduced shunting, with microbubbles appearing after six cardiac cycles, together with concurrent improvement in respiratory function. These findings supported final VV‐ECMO weaning and decannulation on postoperative Day 52. The cumulative duration of VV‐ECMO support was 48 days across two separate runs. After decannulation, the patient required repair of an arteriovenous fistula at the previous cannulation site. An intensive rehabilitation regimen was implemented. The patient was transferred from the intensive care unit 63 days after LT. With nutritional support and rehabilitation, he progressively regained full mobility and was discharged home in good condition on postoperative Day 74. Outcome and Follow‐Up At six‐month follow‐up after discharge, the patient was in good condition and reported no symptoms. Contrast‐enhanced echocardiography showed no clinically significant residual shunt, with only a single microbubble appearing after nine cardiac cycles, consistent with near‐complete resolution of intrapulmonary shunting. Serial changes in intrapulmonary shunting are presented in Figure 1. Liver graft function remained normal, with no clinical or biochemical abnormalities. Evolution of intrapulmonary right‐to‐left shunting assessed by contrast‐enhanced echocardiography. (a) Pre‐LT transthoracic echocardiography showing extensive right‐to‐left intrapulmonary shunting. (b) Intraoperative transesophageal echocardiography performed during the initial VV‐ECMO cannulation, showing microbubbles appearing in the left atrium four cardiac cycles after right‐sided opacification, consistent with persistent intrapulmonary shunting. (c) Transthoracic echocardiography performed 6 months after hospital discharge, showing no clinically significant residual shunt, with only a single microbubble appearing after nine cardiac cycles. LT, liver transplantation; VV‐ECMO, veno‐venous extracorporeal membrane oxygenation. Discussion LT remains the only definitive treatment for HPS; however, improvement in oxygenation may be delayed because regression of intrapulmonary vascular dilatation and right‐to‐left shunting does not occur immediately after restoration of liver function [5, 6]. A recent meta‐analysis found that HPS resolved in approximately 90% of assessed patients by 6 months after LT [6]. Similarly, in a 2025 series of 20 recipients with severe or very severe HPS, persistent hypoxemia was the most frequent post‐LT complication, and the mean time to discontinuation of supplemental oxygen was 250 days [7]. These findings support prolonged respiratory support when graft function is satisfactory and HPS remains potentially reversible. VV‐ECMO may provide a bridge to recovery in patients with refractory HPS‐related hypoxemia after LT [1, 2]. In our patient, VV‐ECMO was selected because respiratory failure occurred without significant cardiac dysfunction. Although pre‐LT PaO2 on room air was 63 mmHg, the post‐LT course was characterized by profound refractory hypoxemia. Immediately before VV‐ECMO re‐initiation, PaO2 was 39.6 mmHg despite an FiO2 of 1.0, corresponding to a PaO2/FiO2 ratio of 39.6 mmHg. The cumulative duration of VV‐ECMO support was 48 days across two separate runs. Successful prolonged ECMO courses lasting 67 and 92 days have previously been reported in patients with HPS after LT [3, 4]. A recent pediatric report also described successful ECMO‐supported recovery from refractory post‐LT hypoxemia [8]. These observations suggest that ECMO duration should not be limited by an arbitrary time threshold when graft function is preserved and recovery remains clinically plausible. A notable feature of this case was recurrent severe hypoxemia following the initial decannulation. This suggests that early improvement in oxygenation may precede stable resolution of intrapulmonary shunting. Serial contrast‐enhanced echocardiography demonstrated persistent shunting during the initial VV‐ECMO cannulation and subsequently documented marked improvement before final decannulation. Although prolonged VV‐ECMO was complicated by bilateral pneumothoraces and an arteriovenous fistula at the cannulation site, both complications were successfully managed. This report is limited by its single‐patient design and the absence of standardized quantitative shunt grading at each echocardiographic assessment. This case therefore supports prolonged VV‐ECMO as a feasible bridge to recovery in carefully selected patients with persistent HPS‐related hypoxemia after LT. Conclusion This case supports prolonged VV‐ECMO as a potential bridge to recovery in carefully selected patients with persistent HPS‐related refractory hypoxemia after LT. Serial assessment of intrapulmonary shunting and multidisciplinary management may aid VV‐ECMO weaning decisions and the management of ECMO‐related complications. Author Contributions Wojciech Figiel: conceptualization, methodology, writing – review and editing, project administration, writing – original draft, funding acquisition, supervision. Anna Drobińska: conceptualization, data curation, investigation, validation, formal analysis, project administration. Paweł Topolewski: conceptualization, methodology, software, data curation, investigation, validation, formal analysis, visualization, resources, writing – original draft, writing – review and editing. Katarzyna Błońska: conceptualization, data curation, investigation, validation, writing – review and editing, project administration, resources. Joanna Banatkiewicz: conceptualization, methodology, writing – original draft. Michał Grąt: writing – review and editing, conceptualization, methodology, software, data curation, investigation, validation, formal analysis, supervision, funding acquisition, visualization, project administration, resources. Mariusz Kuśmierczyk: conceptualization, methodology, software, writing – review and editing, project administration, supervision, funding acquisition, visualization. Waldemar Patkowski: data curation, formal analysis, methodology, writing – review and editing, resources, project administration. Piotr Remiszewski: conceptualization, funding acquisition, visualization, project administration, writing – review and editing. Monika Budnik: conceptualization, methodology, resources, visualization, funding acquisition, supervision, writing – review and editing. Funding The authors have nothing to report. Ethics Statement Ethical approval was not required for this single case report according to local institutional requirements. Consent Written informed consent for publication of the clinical details and accompanying images was obtained from the patient. Conflicts of Interest The authors declare no conflicts of interest.